immunai
Immunai is seeking a candidate to join its Molecular Profiling team in New York City, focusing on improving drug discovery through AI-driven immune system analysis. The role involves performing high-throughput profiling of clinical and experimental samples using single-cell multiomics, flow cytometry, and bulk RNA-seq. The successful candidate will collaborate with a multidisciplinary team of scientists to support the company's goal of reducing drug development failure rates.
Headquarters
New York, New York, United States
Company Size
51-200 employees
Founded
2019
Immunai is a biotechnology company focused on decoding the immune system by mapping it at unprecedented scale and resolution to facilitate the development of next-generation immune-related therapeutics. The company partners with top biopharmaceutical companies and research institutions to support drug discovery and development through solutions including target discovery, preclinical evaluation, and clinical trial optimization. Its platform leverages multiomic data, a large harmonized single-cell immune database (AMICA), and advanced machine learning to deliver actionable insights for drug development strategies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for immunai.
Research Assistant Tissue Profiling (12 Months)
Relation Therapeutics
Postdoctoral Associate - Hematopoiesis and RNA biology
Baylor College of Medicine
Associate Scientist -Molecular Immunology - VIE Contract
Sanofi
Associate Research Scientist / Postdoctoral Associate
Yale University
Senior Scientist, NGS Profiling & Expression
Merck & Co., Inc.
Research Assistant, Tissue profiling
Relation Therapeutics